Ironwood Pharmaceuticals (IRWD) Assets Average (2011 - 2026)

Ironwood Pharmaceuticals (IRWD) has 16 years of Assets Average data on file, last reported at $415.7 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 22.61% year-over-year to $415.7 million; the trailing twelve-month figure through Mar 2026 stood at $415.7 million (up 22.61% YoY), and the FY2025 full-year result was $373.9 million, down 9.02% from the prior year.
• Assets Average climbed to $415.7 million in Q1 2026, from $396.5 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.1 billion in Q1 2023 to a low of $335.1 million in Q2 2025.
• A 5-year average of $633.7 million and a median of $454.9 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average soared 90.78% in 2022 and tumbled 59.66% in 2024, its largest moves.
• Tracing IRWD's Assets Average over 5 years: stood at $1.1 billion in 2022, then tumbled by 53.52% to $497.6 million in 2023, then decreased by 25.6% to $370.2 million in 2024, then advanced by 7.1% to $396.5 million in 2025, then climbed by 4.86% to $415.7 million in 2026.
• Business Quant data shows IRWD's Assets Average at $415.7 million in Q1 2026, $396.5 million in Q4 2025, and $369.5 million in Q3 2025.